These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27718274)

  • 1. The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.
    Leach DA; Trotta AP; Need EF; Risbridger GP; Taylor RA; Buchanan G
    Prostate; 2017 Feb; 77(2):185-195. PubMed ID: 27718274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
    Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
    Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.
    Periyasamy S; Hinds T; Shemshedini L; Shou W; Sanchez ER
    Oncogene; 2010 Mar; 29(11):1691-701. PubMed ID: 20023700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.
    Ni L; Yang CS; Gioeli D; Frierson H; Toft DO; Paschal BM
    Mol Cell Biol; 2010 Mar; 30(5):1243-53. PubMed ID: 20048054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer.
    Febbo PG; Lowenberg M; Thorner AR; Brown M; Loda M; Golub TR
    J Urol; 2005 May; 173(5):1772-7. PubMed ID: 15821585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.
    Wikström P; Marusic J; Stattin P; Bergh A
    Prostate; 2009 Jun; 69(8):799-809. PubMed ID: 19189305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
    Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
    Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease.
    Ricciardelli C; Choong CS; Buchanan G; Vivekanandan S; Neufing P; Stahl J; Marshall VR; Horsfall DJ; Tilley WD
    Prostate; 2005 Apr; 63(1):19-28. PubMed ID: 15378523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer.
    Henshall SM; Quinn DI; Lee CS; Head DR; Golovsky D; Brenner PC; Delprado W; Stricker PD; Grygiel JJ; Sutherland RL
    Cancer Res; 2001 Jan; 61(2):423-7. PubMed ID: 11212224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells.
    Maeda K; Habara M; Kawaguchi M; Matsumoto H; Hanaki S; Masaki T; Sato Y; Matsuyama H; Kunieda K; Nakagawa H; Shimada M
    Mol Oncol; 2022 Feb; 16(4):940-956. PubMed ID: 34057812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.
    Liao CP; Chen LY; Luethy A; Kim Y; Kani K; MacLeod AR; Gross ME
    Endocr Relat Cancer; 2017 Apr; 24(4):157-170. PubMed ID: 28264911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion.
    Li Y; Li CX; Ye H; Chen F; Melamed J; Peng Y; Liu J; Wang Z; Tsou HC; Wei J; Walden P; Garabedian MJ; Lee P
    J Cell Mol Med; 2008 Dec; 12(6B):2790-8. PubMed ID: 18266956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
    Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
    Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
    J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcript levels of androgen receptor variant AR-V1 or AR-V7 do not predict recurrence in patients with prostate cancer at indeterminate risk for progression.
    Zhao H; Coram MA; Nolley R; Reese SW; Young SR; Peehl DM
    J Urol; 2012 Dec; 188(6):2158-64. PubMed ID: 23088973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for the androgen-receptor in clinically localized and advanced prostate cancer.
    Mohler JL
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):357-72. PubMed ID: 18471792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.